EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

5-Oxoproline prevents doxorubicin-induced cardiotoxicity and tumor growth

Xinning Guo, Meng Jiang, Zhengyu Tao, Huijuan Dai, Chen Wu, Yinan Wang, Zi Wang, Xiaoning Wang, Zhixuan Zhang, Kun Qian, Shanshan Zeng, Yihua Bei und 1 weitere

Redox Biology · 2025-09 · 85 · 103753

DOI: 10.1016/j.redox.2025.103753 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Redox Biology, 2025-09. Verfasst von Xinning Guo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shangha…. Hauptthemen laut MEDLINE: Doxorubicin, Cardiotoxicity, Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Commission of Shanghai Municipality, Shanghai Municipal Health Commission, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Doxorubicin (DOX), a classical chemotherapeutic agent, faces significant limitations because of its well-documented risk of inducing cardiotoxicity. Effective prevention of DOX-induced cardiotoxicity is urgently needed. Given that alterations in metabolic pathways have been observed in both cardiovascular diseases and cancer, targeting specific metabolic pathways may offer dual benefits by mitigating DOX-induced cardiotoxicity while simultaneously enhancing its antitumor efficacy. OBJECTIVES: This study sought to explore the characteristic metabolic alterations associated with early DOX-induced cardiotoxicity and identify a therapeutic target that simultaneously inhibits cancer and protects the myocardium. METHODS: Metabolomic and transcriptomic analyses were performed on heart tissues from murine models of DOX-induced cardiotoxicity to identify the most significantly altered metabolic pathway. The most altered metabolite involved in the candidate pathway was chosen and verified in both mice and humans. The protective effects of the chosen metabolite against DOX-induced cardiotoxicity and its antitumor effects were evaluated. Potential mechanisms were explored using C57BL/6J mice, OPLAH global knockout mice, BALB/c nude mice and NSG mice. RESULTS: The glutathione metabolic pathway was identified as the most altered pathway in heart tissues with DOX-induced cardiotoxicity. The 5-oxoproline/OPLAH (5-oxoprolinase) axis was the most critical node. Downregulation of 5-oxoproline was observed in serum samples from both humans and mice. Exogenous 5-oxoproline supplementation effectively restored myocardial 5-oxoproline levels, subsequently mitigating DOX-induced cardiac dysfunction. Interestingly, we observed an additional inhibitory effect of 5-oxoproline on tumor proliferation in tumor-bearing mice treated with DOX. Mechanistically, 5-oxoproline exerts its cardioprotective effects by restoring glutathione metabolic homeostasis through the modulation of its downstream enzyme OPLAH while simultaneously suppressing tumor proliferation by inhibiting its upstream enzyme, gamma-glutamyl cyclotransferase (GGCT). CONCLUSIONS: This study reveals a previously unrecognized dual role of 5-oxoproline, which functions both as an early biomarker for DOX-induced cardiotoxicity detection and as a therapeutic target that simultaneously inhibits cancer growth and protects the myocardium.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinCardiotoxicityNeoplasmsAnimalsMiceHumansCell ProliferationCell Line, TumorAntibiotics, AntineoplasticMice, Inbred C57BLDisease Models, AnimalMaleMice, KnockoutMyocardium

Stichwörter der Autor:innen

5-oxoprolineBreast cancerCardio-oncologyCardiotoxicityDoxorubicinHeart failure

Substanzen

DoxorubicinAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • Department of Cardiology, State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
  • Department of Cardiology, State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China. Electronic address: j…
  • Department of Breast Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
  • School of Biomedical Engineering, Institute of Medical Robotics and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, 200030, China.
  • Cardiac Regeneration and Aging Lab, Institute of Cardiovascular Sciences, Shanghai Engineering Research Center of Organ Repair, School of Life Sciences, Shanghai University, Shanghai, 200444, China. Electronic address:…
  • Department of Cardiology, State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China. Electronic address: p…

Förderung

  • Science and Technology Commission of Shanghai Municipality
  • Shanghai Municipal Health Commission
  • National Natural Science Foundation of China

Zitieren

APA

Guo, X., Jiang, M., Tao, Z., Dai, H., Wu, C., Wang, Y., Wang, Z., Wang, X., Zhang, Z., Qian, K., Zeng, S., Bei, Y., & Pu, J. (2025). 5-Oxoproline prevents doxorubicin-induced cardiotoxicity and tumor growth. Redox Biology, 85, 103753. https://doi.org/10.1016/j.redox.2025.103753

Vancouver

Guo X, Jiang M, Tao Z, Dai H, Wu C, Wang Y, et al. 5-Oxoproline prevents doxorubicin-induced cardiotoxicity and tumor growth. Redox Biology. 2025;85:103753. doi:10.1016/j.redox.2025.103753

BibTeX
@article{Guo2025,
  author = {Guo, Xinning and Jiang, Meng and Tao, Zhengyu and Dai, Huijuan and Wu, Chen and Wang, Yinan and Wang, Zi and Wang, Xiaoning and Zhang, Zhixuan and Qian, Kun and Zeng, Shanshan and Bei, Yihua and Pu, Jun},
  title = {5-Oxoproline prevents doxorubicin-induced cardiotoxicity and tumor growth},
  journal = {Redox Biology},
  year = {2025},
  volume = {85},
  pages = {103753},
  doi = {10.1016/j.redox.2025.103753}
}
Kostenlos starten →